top of page

HOME
ABOUT
MMAR
CANNABIS ACT
PATIENTS
CLIENTS
CONTACT
More...

Use tab to navigate through the menu items.

Huntingon's Disease

Microglial_CB2_cannabinoid_receptors_are_neuroprotective_in_Huntington’s_disease_excitotoxicity.pdf

(5) Huntington’s.pdf

The pattern of neurodegeneration in Huntington's disease- a comparative study of cannabinoid, dopamine, adenosine and GABAA receptor alterations in the human basal ganglia in Huntington's disease.pdf

bottom of page